STAndardization of Reports (the STAR project) Upper gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative
- PMID: 40834875
- DOI: 10.1055/a-2652-8941
STAndardization of Reports (the STAR project) Upper gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative
Abstract
Upper gastrointestinal (UGI) endoscopy is the mainstay for the diagnosis and staging of precancerous and cancerous conditions of the esophagus, stomach, and duodenum. Despite development of several validated classifications for UGI diseases, endoscopy reports differ between endoscopists and endoscopy departments. This document proposes a standardized high quality UGI endoscopy report, including preprocedural, periprocedural, endoscopic findings, and postprocedural information. Preprocedural details should comprise data on the patient, exam, use of antithrombotic drugs, fasting, and premedication. Periprocedural information should report on medications administered, endoscope used, and the mucosal cleanliness assessment. Endoscopic findings should describe the esophagus, stomach, and duodenum, with any observed abnormalities reported using the most commonly employed classification (provided in the document). Postprocedural details should include data on biopsies and vials, pictures taken during the procedure, and the exam duration. A suggestion for a normal findings report is provided. Standardized reporting could enhance the quality of UGI endoscopy.
Upper gastrointestinal (UGI) endoscopy is the mainstay for the diagnosis and staging of precancerous and cancerous conditions of the esophagus, stomach, and duodenum. Despite development of several validated classifications for UGI diseases, endoscopy reports differ between endoscopists and endoscopy departments. This document proposes a standardized high quality UGI endoscopy report, including preprocedural, periprocedural, endoscopic findings, and postprocedural information. Preprocedural details should comprise data on the patient, exam, use of antithrombotic drugs, fasting, and premedication. Periprocedural information should report on medications administered, endoscope used, and the mucosal cleanliness assessment. Endoscopic findings should describe the esophagus, stomach, and duodenum, with any observed abnormalities reported using the most commonly employed classification (provided in the document). Postprocedural details should include data on biopsies and vials, pictures taken during the procedure, and the exam duration. A suggestion for a normal findings report is provided. Standardized reporting could enhance the quality of UGI endoscopy.
European Society of Gastrointestinal Endoscopy. All rights reserved.
Conflict of interest statement
M. Barthet has received research grants from Boston Scientific (2018–2024) and Endotools (2019–2025), and has provided consultancy to Taewoong (2021–2025). J. Bornschein receives an advisory board fee from Juvisé (April 2025–March 2026). I. Hritz has consultancy and training links with Olympus (from 2017, ongoing) and consultancy and speaker links with MicroTech (from 2023, ongoing). A. Monged has received sponsorship from Fuji (2-day endoscopy course, June 2025) and Ovesco (1-day endoscopy course, March 2025). E. Rodriguez de Santiago has participated in educational activities with, provided consultancy to, and received speaker’s fees and research grants from Olympus, Izasa, ERBE, Apollo, 3 D Matrix, and Norgine (2017–2025). P. Siersema’s department has received research support from Pentax (since 2015), Fujifilm (since 2023), and MicroTech (since 2017). S. Afify, M. Areia, M. Arvanitakis, P. Bhandari, R. Bisschops, I. Boskoski, H.-L. Ching, P.G. Delgado Guillena, B. Eross, G. Esposito, M. Ferlitsch, I.M. Gralnek, C. Hassan, R. Honrubia López, A. Hopper, P. Leclercq, V. Lorenzo-Zuniga, T. Lux, N. McGettigan, H. Messmann, O.O. Oguntoye, A. Panarese, I. Papanikolaou, L.A. Reis De Oliveira, M. Romańczyk, E.J. Ruiz Ballesteros, F.W.D. Tai, T. Tham, K. Triantafyllou, H.I. Uchima, A.M. Voiosu, and Jasmin Zessner-Spitzenberg declare no competing interests.